Detail

Study ID: CSL Behring CSL112-3001 Acute Coronary Syndrome

Title:

A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome

Description:
A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome –the AEGIS-II Study. Participants in this study have experienced a recent heart attack. The most common cause is the build-up of excess cholesterol, which results in fatty deposits that cause the artery to become narrower.
Location:
Fargo Region
Principal Investigator:
Hayan Al Maluli, MD
Disease:
Heart
Stage:
Phase III
Status:
Active - Open to Accrual